Outlook For Biotechnology: John Rhodes – Deloitte & Touche
JOHN D. RHODES, CPA, is Deloitte & Touche's Managing Partner for
Pharmaceuticals and Life Sciences. In this role, he is
responsible for the firm's services to pharmaceutical,
biotechnology and medical technology and device companies. Mr.
Rhodes has significant experience with pharmaceutical,
manufacturing and process industries, focusing on accounting and
auditing, SEC reporting, business process and contracting issues,
corporate compliance, strategic alliances, research and promotion
collaborations, joint venture formations and mergers and
acquisitions. He has published in Pharmaceutical Executive and
has co-authored firm publications on the Life Sciences industry.
He is a member of the firm's Manufacturing Industry Operating
TWST: What are the current fundamentals that underlie merger and
acquisition activity versus what they were six to 12 months ago?
Mr. Rhodes: The forces today have evolved from six months